Aug 22, 2025 • Benzinga
NEUTRAL
SRPT 3-DAY DEADLINE ALERT: Hagens Berman Urges Sarepta Investors to Act Before August 25 Deadline - Sarepta Therapeutics ( NASDAQ:SRPT )
SAN FRANCISCO, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- A securities class-action lawsuit is underway against Sarepta Therapeutics SRPT, triggered by a series of safety concerns and regulatory setbacks for its gene therapy, ELEVIDYS. The lawsuit alleges that Sarepta misled investors by presenting ...
Aug 22, 2025 • Benzinga
NEUTRAL
SRPT FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Sarepta Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action - SRPT - Sarepta Therapeutics ( NASDAQ:SRPT )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. SRPT between June 22, 2023 and June 24, 2025, both dates inclusive ( the "Class Period" ) , of the important August 25, 2025 ...
Aug 21, 2025 • Benzinga
NEUTRAL
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT - Sarepta Therapeutics ( NASDAQ:SRPT )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. ( "Sarepta" or the "Company" ) SRPT. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ( or ...
Aug 21, 2025 • Benzinga
SOMEWHAT-BULLISH
What's Going On With Sarepta Shares Thursday? - Sarepta Therapeutics ( NASDAQ:SRPT )
Sarepta swaps $700 million of 2027 notes for $602 million of new 2030 notes, stock, and cash. The new notes convert at $60 per share, a 191.5% premium to the last close of $20.58. Get the exact trades and sectors to target before August's biggest earnings-driven market moves. Details here →
Aug 21, 2025 • Benzinga
NEUTRAL
SRPT DEADLINE NOTICE: Sarepta Therapeutics, Inc. Investors are Notified of the August 25 Class Action Deadline -- Contact BFA Law if You Suffered Losses ( NASDAQ:SRPT ) - Sarepta Therapeutics ( NASDAQ:SRPT )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Sarepta Therapeutics, Inc. SRPT and certain of the Company's senior executives for potential violations of the federal securities laws.
Aug 21, 2025 • Benzinga
NEUTRAL
INVESTOR DEADLINE MONDAY: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - SRPT - Sarepta Therapeutics ( NASDAQ:SRPT )
SAN DIEGO, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. SRPT securities between June 22, 2023 and June 24, 2025, inclusive ( the "Class Period" ) , have until Monday, August 25, 2025 to seek appointment ...